The stability of dihydropyrimidine dehydrogenase activity in colorectal cancer tissue after resection

Oncology Reports

Volumn 10, Issue 4, 2003, Pages 867-869

  Sadahiro, Sotaro ^a   Suzuki, Toshiyuki ^a   Ishikawa, Kenji ^a   Nakamura, Tomoki ^a   Kamijo, Akemi ^a   Saguchi, Takeshi ^a   Yasuda, Seiei ^a   Tajima, Tomoo ^a   Makuuchi, Hiroyasu ^a   Murayama, Chieko ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Dihydropyrimidine dehydrogenase

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BIOPSY; COLORECTAL TUMOR; ENZYME STABILITY; ENZYMOLOGY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; TIME;

ADULT; AGED; BIOPSY; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); ENZYME STABILITY; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 1542787636     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.4.867     Document Type: Article

References (17)

1. Diasio RB and Harris BE: Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 16: 215-237, 1989. (Pubitemid 19114713)
2. Beck A, Etienne MC, Chéradame S, Fischel JL, Formento P, Renée N and Milano G: A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil. Eur J Cancer 30A: 1517-1522, 1994. (Pubitemid 24343014)
3. Etienne MC, Chéradame S, Fischel JL, Formento P, Dassonville O, Renée N, Schneider M, Thyss A, Demard F and Milano G: Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13: 1663-1670, 1995.
4. Jiang W, Lu Z, He Y and Diasio RB: Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res 3: 395-399, 1997. (Pubitemid 27158063)
5. Guimbaud R, Guichard S, Dusseau C, Bertrand V, Aparicio T, Lochon I, Chatelut E, Couturier D, Bugat R, Chaussade S and Canal P: Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans. Cancer Chemother Pharmacol 45: 477-482, 2000. (Pubitemid 30316908)
6. McLeod HL, Sludden J, Murray Gl, Keenan RA, Davidson AI, Park K, Koruth M and Cassidy J: Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. Br J Cancer 77: 461-465, 1998. (Pubitemid 28044052)
7. Ikeuchi M, Hirooka Y, Makino M and Kaibara N: Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestines. Oncol Rep 8: 621-625, 2001.
8. Lu Z, Zhang R and Diasio RB: Dihydropyrimidine dehydrogenase activity in human peripheral blood mononuclear cells and liver: population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy. Cancer Res 53: 5433-5438, 1993. (Pubitemid 23342163)
9. Naguib FNM, El Kouni MH and Cha S: Enzymes of uracil catabolism in normal and neoplastic human tissues. Cancer Res 45: 5405-5412, 1985. (Pubitemid 16200794)
10. Ikenaka K, Shirasaka T, Kitano S and Fujii S: Effect of uracil on metabolism of 5-fluorouracil in vitro. Gann 70: 353-359, 1979. (Pubitemid 9243954)
11. Takechi T, Uchida J, Takeda S and Fukushima M: Enhancement 5-fluorouracil cytotoxity by inhibiting dihydropyrimidine dehydrogenase inhibitor, 5-chloro-2,4-dehydroxypyrimidine. Proc Jpn Cancer Assoc 87: 639, 1996.
12. Milano G and Etienne MC: Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil (review). Anticancer Res 14: 2295-2298, 1994.
13. Heggie GD, Sommadossi JP, Cross DS, Huster WJ and Diasio RB: Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Cancer Res 47: 2203-2206, 1987. (Pubitemid 17074634)
14. Chazal M, Etienne MC, Renée N, Bourgeon A, Richelme H and Milano G: Link between dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cells and liver. Clin Cancer Res 2: 507-510, 1996. (Pubitemid 26099171)
15. Etienne MC, Lagrange JL, Dassonville O, Fleming R, Thyss A, Renée N, Schneider M, Demard F and Milano G: Population study of dihydropyrimidine dehydrogenase in cancer patients. J Clin Oncol 12: 2248-2253, 1994. (Pubitemid 24346691)
16. Uetake H, Ichikawa W, Takechi T, Fukushima M, Nihei Z and Sugihara K: Relationship between intratumoral dihydropyrimidine dehydrogenase activity and gene expression in human colorectal cancer. Clin Cancer Res 5: 2836-2839, 1999. (Pubitemid 29493960)
17. Ahmed FY, Johnston SJ, Cassidy J, O'Kelly T, Binnie N, Murray GI, van Gennip AH, Abeling NGGM, Knight S and McLeod HL: Eniluracil treatment completely inactivates dihydropyrimidine dehydrogenase in colorectal tumors. J Clin Oncol 17: 2439-2445, 1999. (Pubitemid 29368243)